Back to search
FDAFDA · Food and drugs·Recall number Z-1249-2019

cobas e 801 immunoassay analyzer

Published May 8, 2019 · Recall initiated: March 15, 2019

Summary

FDA records medical device Class II recall Z-1249-2019, published May 8, 2019 and initiated March 15, 2019. Recalling firm: Roche Diagnostics Corporation; Status: Terminated; Reported quantity: 149; Lot: All units may experience this issue. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The firm has confirmed complaints regarding signal drops on the cobas e 801 module after a ProCell II M bottle changeover, which may lead to incorrect medical decisions with respect to diagnostics and patient treatment.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Roche Diagnostics Corporation
Distributor
Distributed to accounts in AL AZ CA CT FL HI IA IL IN KY LA MA MD ME MI MN MO NC NH NJ NY OH OR PA PR SC TN TX VA WA WI
Lot
All units may experience this issue.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was cobas e 801 immunoassay analyzer recalled?

Yes. FDA published recall Z-1249-2019 on May 8, 2019. Reported hazard: The firm has confirmed complaints regarding signal drops on the cobas e 801 module after a ProCell II M bottle changeover, which may lead to incorrect medical decisions with respect to diagnostics and patient treatment.

What should I do if I have this product?

Voluntary: Firm initiated · Letter